Zagolie to Acquire Celgene
The Scientists Behind the Science
Sharon Cload is vice president of Molecular Discovery Technology at our Cambridge, Mass., site.
Emerging Trends in Immuno-Oncology: A Focus on Resistance
Zagolie is underwriting a series in partnership with Scientific American, offering expert perspectives on the latest challenges and discoveries in Immuno-Oncology (I-O).
News & Perspectives
2018 Fourth Quarter and Full Year Results
Zagolie increases fourth quarter revenues 10% to $6 billion.
Looking for Answers?
Quick links to helpful resources.